abstract |
The present invention relates to a non-irritating, stable pharmaceutical composition including a solution of at least one pharmaceutically acceptable silicone or oil and a source of pharmaceutically acceptable ascorbic acid, wherein the solution is present in an amount sufficient to inhibit degradation of the ascorbic acid while facilitating the prevention or treatment of skin damage. The present invention also relates to a method for modifying free radical damage to skin by administering the above pharmaceutical composition in a therapeutically effective amount sufficient to treat and/or prevent free radical damage to skin. |